Featured in Weekly Newsletter
Remember the questionable study claiming glyphosate boosts cancer risk 41%? Lead author reasserts her claim, EPA refutes it, and we take a second look
Sheppard and her co-authors are intent on favoring data that appears to support the existence of a risk from glyphosate ...
Searching for the ‘big break’ that could turn stem cells into a weapon against dementia
Recent developments in stem cell research suggest a radical shift in the way we diagnose and treat dementia ...
Viewpoint: We can sustainably feed 10 billion people. Here’s how CRISPR and GMO crops can help
If adopted widely, genetic engineering will bring us closer to meeting the EAT-Lancet dietary targets ...
Gene therapy shows success against some cancers and inherited disorders. Can it tackle obesity?
Scientists are working with treatments that have shown success in amping up the metabolism of mice, helping them lose weight ...
Gene drives could revolutionize how we deal with pests—if the technology avoids the controversial fate of GMOs
In addition to research and laboratory ethics, gene drive proponents need to focus on public perception ...
Why the UK wants to share everything it knows about the genetics of 500,000 Britons
Britain is profiling the genes, health and lifestyles of its citizens and handing the results to scientists across the world ...
Podcast: Tackling ethical questions about CRISPR with GLP’s groundbreaking Global Gene Editing Regulation Tracker and Index
To what degree are nations deploying these revolutionary new tools? ...
Viewpoint: Glyphosate causes kidney disease? Debunking anti-GMO activist Vandana Shiva’s herbicide junk science
Seeing Vandana Shiva hosted at the University of California made me embarrassed to be a UC parent, alum, and faculty ...
Examining our history of advertising for OxyContin and other opioids: Have we learned enough about the dangers of addiction?
Recent advertising for opioid drugs has taken a strange turn ...
Viewpoint: Is a coronavirus vaccine on the horizon? Antiquated FDA regulations make it unlikely one will emerge in the US
A coronavirus vaccine in the foreseeable future? I’m not holding my breath ...
Podcast: ‘How to argue with a racist’—geneticist Adam Rutherford challenges what he calls ‘pseudoscience’ in genetics and politics
Adam Rutherford explains how to argue with a racist, hunting for the ghosts in the human genome, and recreating the ...
Salt tolerant plants are on the horizon – and critical to address the looming crisis of a shortage of arable farm land
An important study brings us one step closer to cultivating crops in previously infertile soil ...
Viewpoint: French court ruling that already-approved mutagenized crops should be heavily restricted as GMOs reaffirms need to revamp Europe’s antiquated biotech regulations
This judgment raises serious and important questions ...
New ‘DNA clock’ finds that if our genes had their way, humans would have a ‘natural’ lifespan of 38 years
A genetic “clock” lets scientists estimate how long extinct creatures lived ...
Viewpoint: ‘Dicamba Debacle’ stirs questions about the future shape of ‘industrial, intensive agriculture’
The dicamba debacle gives a chance to answer key questions about industrial agriculture with rare specificity ...
Podcast: How ‘fake news’ about avian flu almost sent virologist Ilaria Capua to prison for life
Capua now uses her harrowing experience to educate policymakers and law enforcement about science ...
Viewpoint: Dicamba debacle trial forces a reevaluation: Was Monsanto a ‘bonafide bad actor’?
The toll on farmers is infuriating enough. But there could be widespread damage to the environment as well ...
Will scientists ever get ahead of fast-mutating deadly health viruses? Exploring the coronavirus and the genetics of other viral outbreaks
Even as our methods of detection and treatment improve, we will likely never be able to completely stay ahead of ...
FDA defends CRISPR-edited animal rules likely to block most uses: Is the agency trying to avoid litigation from anti-GMO groups?
"How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?" ...
Manipulating our internal clocks could lead to treatments for mood disorders, obesity—and even aging
Medicines and other small molecules may play a role in fixing rhythms gone awry ...
Viewpoint: Biotechnology could save our favorite banana. Will anti-GMO activists stand in the way?
Anti-GMO intimidation could plunge banana-producing communities into poverty ...
Brain chemicals fight for the status quo—that’s why it’s so hard to change people’s minds even when the science consensus is overwhelming
Why do people refuse to change their views when confronted with scientific consensus? Research is starting to show us how ...
With Roundup-cancer settlement looming, activists revive conspiracy claim that glyphosate surfactants threaten human health
The narrative of underdog cancer victims unmasking corporate villains isn't backed up by the evidence ...
Would artificial wombs liberate women from the ‘blood, sweat and tears’ of pregnancy?
By lifting the burden of reproduction, artificial wombs might liberate women ...
‘More than human’: How neural implants, robotics and artificial intelligence are redefining who we are
Advances in human enhancement make cyborgs a future possibility ...
Viewpoint: Almond growers driving bees to ‘extinction’? Challenging the latest pollinator decline scare story
The policies of greens are a greater threat to wildlife than high-yield agriculture ...
‘Monsanto on the attack’: How an aggressive defense contributed to the ‘dicamba debacle’
It's pretty clear that the ag industry has a problem. But what is the nature of it? ...
